Cited by 28Cell death mechanisms and regulationImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Apoptotic caspases cut down the immunogenicity of radiation

Open access
Buqué, Aitziber, Rodriguez-Ruiz, Maria Esperanza, Fucikova, Jitka, Galluzzi, Lorenzo·2019·OncoImmunology

Abstract

Caspases are known for their ability to precipitate apoptosis. Our findings indicate that accelerating the terminal inactivation of cells dying in response to radiation therapy limit their immunogenicity as a consequence of reduced type I interferon secretion. Thus, caspase inhibitors stand out as promising combinatorial partners to improve the immunogenicity of radiation therapy in the clinic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/2162402x.2019.1655364

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Similar immune effects arise from accessing extranuclear CGAS-activating DNA via permeabilized mitochondria, through autophagy or BCL2 inhibition, and from delaying caspase-dependent apoptotic breakdown after mitochondrial permeabilization.

    “Similar results have been obtained by actioning extranuclear sources of CGAS-activatory DNA such as permeabilized mitochondria (by autophagy or BCL2 inhibition) (Yamazaki et al., 2020), as well as by delaying the terminal breakdown of cancer cells undergoing caspasedependent apoptosis upon mitochondrial permeabilization (Buque ´ et al., 2019; Han et al., 2020a; Rodriguez-Ruiz et al., 2019).”

    From Immunomodulation by targeted anticancer agents (2021) · cites this paper as Buque ´ et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 11 · Cited by 28

Authors
Buqué, A., Rodriguez-Ruiz, M. E., Fucikova, J., & Galluzzi, L.
Affiliations
  • Weill Cornell Medicine (US)
  • Clinica Universidad de Navarra (ES)
  • Charles University (CZ)
  • Yale University (US)
Corresponding author
Galluzzi, Lorenzo
Venue
OncoImmunology
Published
2019-08-20
Volume
8
Issue
11
Pages
e1655364
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W2969395289
Cited by
28
References
11
Citations by year
2025: 1 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 13 · 2019: 1
FWCI
1.74
Type
journal article
Language
en
Open access
Locations
  • OncoImmunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Defense (#BC180476P1)
  • Weill Cornell Medical College
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
caspases, radiation-induced apoptosis, type I interferon, caspase inhibitors, radiotherapy, cancer immunotherapy, cancer cell death

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review